[1] |
World Health Organization.Global tuberculosis report 2018[R]. Geneva:WHO,2018.
|
[2] |
TRIPATHI R,ANUPURBA S.Multidrug-resistant tuberculosis detection and characterization of mutations in Mycobacterium tuberculosis by genotype MTBDRplus[J].Indian J Pathol Microbiol,2017,60(2):239-242.
|
[3] |
DING P,LI X,JIA Z,et al.Multidrug-resistant tuberculosis (MDR-TB) disease burden in China:a systematic review and spatio-temporal analysis[J]. BMC Infect Dis,2017,17(1):57.
|
[4] |
PENG Y,CHEN S H,ZHANG L,et al.Multidrug-resistant tuberculsis burden among the new tuberculosis patients in Zhejiang Province:an observational study,2009-2013[J]. Chin Med J(Engl),2017,130(17):2021-2026.
|
[5] |
蔡金凤,张桂红,郑江花. 2012—2016年上海地区AIDS患者分枝杆菌分离及耐药情况分析[J]. 检验医学,2018,33(12):1071-1075.
|
[6] |
周伟杰,王文,刘同杰. 5 937例结核病患者非结核分枝杆菌感染及其对抗结核药物耐药情况分析[J]. 山东医药,2016,56(12):72-73.
|
[7] |
贾庆军,谢立,吴亦斐,等. 杭州市结核病患者耐药检测结果分析[J]. 预防医学,2019,31(3):289-292.
|
[8] |
XU Y,WU J,LIAO S,et al.Treating tuberculosis with high doses of anti-TB drugs:mechanisms and outcomes[J]. Ann Clin Microbiol Antimicrob,2017,16(1):67.
|
[9] |
曾方林,束玉凤,王金富. 扬州地区结核分枝杆菌对利福平与异烟肼耐药基因突变位点分布特征分析[J]. 现代医药卫生,2018,34(9):1298-1299.
|